MetaCap

Enlivex (ENLV) vs 60 Degrees Pharmaceuticals (SXTP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

60 Degrees Pharmaceuticals is the larger company by market cap ($2.1 million vs $2.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ENLV+242.69%SXTP-57.44%
+823%+362%-99%
Oct 7, 20261 yearNov 20, 2026
ENLV+313.39%SXTP-51.50%
+633%+275%-84%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ENLV versus SXTP key metrics
MetricENLVSXTP
Share price$1.05$0.4682
Market cap$2.01M$2.10M
1-day change-11.76%-6.36%
P/E ratio (TTM)0.00—
EPS (TTM)$7,904.00$-5.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.01M
Revenue growth (YoY)—+65.49%
Net income (latest FY)$1.24B$-7.37M
Gross margin—22.26%
Operating margin—-771.64%
Net margin—-732.51%
52-week high$434.40$8.62
52-week low$1.00$0.46
Distance from 52-week high-99.76%-94.57%
Analyst consensusnonenone
Avg. price target upside+7519.05%+690.26%
Average volume73.14K407.29K
Shares outstanding1.91M4.48M
Employees343
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Enlivex

ENLV stock →

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2.

Health Care · Biotechnology: Pharmaceutical Preparations · 34 employees

About 60 Degrees Pharmaceuticals

SXTP stock →

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

ENLV vs SXTP FAQ

Which is bigger, Enlivex or 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (SXTP) is larger, with a market capitalization of $2.10M compared with $2.01M for Enlivex (ENLV).

Are Enlivex and 60 Degrees Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons